These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34921425)

  • 1. Evaluation of hydrogen peroxide efficacy against AZD1222 chimpanzee adenovirus strain in the recombinant COVID-19 vaccine for application in cleaning validation in a pharmaceutical manufacturing industry.
    Ajorio ACFB; Rhodes VP; Rodrigues AP; Diniz VA; Mattoso JMV; da Silva IB; D Aiuto DMM; Brandão MLL
    Lett Appl Microbiol; 2022 Apr; 74(4):536-542. PubMed ID: 34921425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of hydrogen peroxide wipes for decontamination of AZD1222 adenovirus COVID-19 vaccine strain on pharmaceutical industry materials.
    Rhodes VP; Ajorio ACFB; da Costa LV; Rodrigues AP; Diniz VA; da Silva Lage RV; da Silva IB; Brandão MLL
    Lett Appl Microbiol; 2022 Dec; 75(6):1639-1644. PubMed ID: 36073022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of hydrogen peroxide virucidal efficacy against yellow fever virus 17DD vaccine strain for application in a vaccine manufacturing industry.
    Ferreira Ballestê Ajorio AC; Pessanha Rhodes V; Peclat Rodrigues A; Mercês Moreira F; Alvaro Diniz V; Machado Vieira Mattoso J; Barbosa da Silva I; da Silva Guedes Junior D; Lima Brandão ML
    J Pharm Biomed Anal; 2021 Sep; 204():114264. PubMed ID: 34274595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manufacturing a chimpanzee adenovirus-vectored SARS-CoV-2 vaccine to meet global needs.
    Joe CCD; Jiang J; Linke T; Li Y; Fedosyuk S; Gupta G; Berg A; Segireddy RR; Mainwaring D; Joshi A; Cashen P; Rees B; Chopra N; Nestola P; Humphreys J; Davies S; Smith N; Bruce S; Verbart D; Bormans D; Knevelman C; Woodyer M; Davies L; Cooper L; Kapanidou M; Bleckwenn N; Pappas D; Lambe T; Smith DC; Green CM; Venkat R; Ritchie AJ; Gilbert SC; Turner R; Douglas AD
    Biotechnol Bioeng; 2022 Jan; 119(1):48-58. PubMed ID: 34585736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen peroxide vapour (HPV) inactivation of adenovirus.
    Berrie E; Andrews L; Yezli S; Otter JA
    Lett Appl Microbiol; 2011 May; 52(5):555-8. PubMed ID: 21418259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Novel Process Indicators for Rapid Monitoring of Hydrogen Peroxide Decontamination Processes.
    McLeod NP; Clifford M; Sutton JM
    PDA J Pharm Sci Technol; 2017; 71(5):393-404. PubMed ID: 28512177
    [No Abstract]   [Full Text] [Related]  

  • 7. Virucidal efficacy of hydrogen peroxide vapour disinfection.
    Tuladhar E; Terpstra P; Koopmans M; Duizer E
    J Hosp Infect; 2012 Feb; 80(2):110-5. PubMed ID: 22153909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the virucidal efficacy of hydrogen peroxide vapour.
    Goyal SM; Chander Y; Yezli S; Otter JA
    J Hosp Infect; 2014 Apr; 86(4):255-9. PubMed ID: 24656442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores.
    Johnston MD; Lawson S; Otter JA
    J Microbiol Methods; 2005 Mar; 60(3):403-11. PubMed ID: 15649542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of two hydrogen peroxide vapour aerial decontamination systems for enhanced disinfection of meticillin-resistant Staphylococcus aureus, Klebsiella pneumoniae and Clostridium difficile in single isolation rooms.
    Ali S; Muzslay M; Bruce M; Jeanes A; Moore G; Wilson AP
    J Hosp Infect; 2016 May; 93(1):70-7. PubMed ID: 26944907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hydrogen peroxide vapor for the inactivation of nosocomial pathogens on porous and nonporous surfaces.
    Lemmen S; Scheithauer S; Häfner H; Yezli S; Mohr M; Otter JA
    Am J Infect Control; 2015 Jan; 43(1):82-5. PubMed ID: 25564129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hazard Group 3 agent decontamination using hydrogen peroxide vapour in a class III microbiological safety cabinet.
    Pottage T; Lewis S; Lansley A; Fraser S; Hendon-Dunn C; Bacon J; Ngabo D; Parks SR; Bennett AM
    J Appl Microbiol; 2020 Jan; 128(1):116-123. PubMed ID: 31559683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meticillin-resistant Staphylococcus aureus is more resistant to vaporized hydrogen peroxide than commercial Geobacillus stearothermophilus biological indicators.
    Pottage T; Macken S; Walker JT; Bennett AM
    J Hosp Infect; 2012 Jan; 80(1):41-5. PubMed ID: 22137066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virucidal Activity of Fogged Chlorine Dioxide- and Hydrogen Peroxide-Based Disinfectants against Human Norovirus and Its Surrogate, Feline Calicivirus, on Hard-to-Reach Surfaces.
    Montazeri N; Manuel C; Moorman E; Khatiwada JR; Williams LL; Jaykus LA
    Front Microbiol; 2017; 8():1031. PubMed ID: 28642746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.
    Marsh GA; McAuley AJ; Au GG; Riddell S; Layton D; Singanallur NB; Layton R; Payne J; Durr PA; Bender H; Barr JA; Bingham J; Boyd V; Brown S; Bruce MP; Burkett K; Eastwood T; Edwards S; Gough T; Halpin K; Harper J; Holmes C; Horman WSJ; van Vuren PJ; Lowther S; Maynard K; McAuley KD; Neave MJ; Poole T; Rootes C; Rowe B; Soldani E; Stevens V; Stewart CR; Suen WW; Tachedjian M; Todd S; Trinidad L; Walter D; Watson N; Drew TW; Gilbert SC; Lambe T; Vasan SS
    NPJ Vaccines; 2021 May; 6(1):67. PubMed ID: 33972565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of hydrogen peroxide gaseous disinfection systems to decontaminate viruses.
    Pottage T; Richardson C; Parks S; Walker JT; Bennett AM
    J Hosp Infect; 2010 Jan; 74(1):55-61. PubMed ID: 19931937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, efficiency and safety aspects of hydrogen peroxide vapour and aerosolized hydrogen peroxide room disinfection systems.
    Fu TY; Gent P; Kumar V
    J Hosp Infect; 2012 Mar; 80(3):199-205. PubMed ID: 22306442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Decontamination: A Case Study on Kill Efficacy of Geobacillus stearothermophilus Spores on Different Carrier Materials.
    Semmler E; Novak W; Allinson W; Wallis D; Wood N; Awakowicz P; Wunderlich J
    PDA J Pharm Sci Technol; 2016; 70(3):256-71. PubMed ID: 27020647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.